Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy
…, S Ueda, M Takahara, T Kumai, K Ishibashi… - Cancer Immunology …, 2017 - Springer
Nasal natural killer/T-cell lymphoma (NNKTL) is an aggressive neoplasm with poor therapeutic
responses and prognosis. The programmed death-1/programmed death-ligand 1 (PD-1/…
responses and prognosis. The programmed death-1/programmed death-ligand 1 (PD-1/…
Etiology of Severe Sensorineural Hearing Loss in Children: Independent Impact of Congenital Cytomegalovirus Infection and GJB2 Mutations
…, S Koyano, N Nozawa, K Ishibashi… - The Journal of …, 2007 - academic.oup.com
Background. Sensorineural hearing loss (SNHL) is the most common congenital disease.
Longitudinal studies of infants with congenital cytomegalovirus (CMV) infection have …
Longitudinal studies of infants with congenital cytomegalovirus (CMV) infection have …
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site
T Ohkuri, A Kosaka, K Ishibashi, T Kumai… - Cancer Immunology …, 2017 - Springer
Stimulator of IFN genes (STING) spontaneously contributes to anti-tumor immunity by inducing
type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the tumor-…
type I interferons (IFNs) following sensing of tumor-derived genomic DNAs in the tumor-…
Urinary incontinence after robot‐assisted radical prostatectomy: Pathophysiology and intraoperative techniques to improve surgical outcome
…, M Nomiya, T Yanagida, K Ishibashi… - … Journal of Urology, 2013 - Wiley Online Library
Robot‐assisted radical prostatectomy has been shown to have comparable and possibly
improved postoperative continent rates compared with retropubic and laparoscopic radical …
improved postoperative continent rates compared with retropubic and laparoscopic radical …
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
A Kosaka, K Ishibashi, T Nagato, H Kitamura… - Journal of Experimental …, 2021 - rupress.org
Activation of STING signaling plays an important role in anti-tumor immunity, and we previously
reported the anti-tumor effects of STING through accumulation of M1-like macrophages …
reported the anti-tumor effects of STING through accumulation of M1-like macrophages …
Interleukin-6 induces drug resistance in renal cell carcinoma
K Ishibashi, T Koguchi, K Matsuoka, A Onagi… - Fukushima journal of …, 2018 - jstage.jst.go.jp
Metastatic renal cell carcinoma (mRCC) is a tumor entity with poor prognosis due to limited
therapy options. Tyrosine kinase inhibitors (TKIs), the novel targeted agents have been used …
therapy options. Tyrosine kinase inhibitors (TKIs), the novel targeted agents have been used …
[HTML][HTML] Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade
K Ishibashi, T Haber, I Breuksch, S Gebhard, T Sugino… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Metastatic renal cell carcinoma (RCC) is a tumor entity with poor prognosis due to limited
therapy options. Tyrosine kinase inhibitors (TKI) represent the standard of care for RCCs, …
therapy options. Tyrosine kinase inhibitors (TKI) represent the standard of care for RCCs, …
A newly developed continuous zoom-focus endocytoscope
…, T Ishiguro, J Sobajima, M Fukuchi, K Ishibashi… - …, 2017 - thieme-connect.com
Background and study aims We report the features of a newly developed endocytoscopy
system (ECS), the GIF-Y0074. Patients and methods The GIF-Y0074 offers high-definition …
system (ECS), the GIF-Y0074. Patients and methods The GIF-Y0074 offers high-definition …
Esophageal schwannoma: a case report
M Kitada, Y Matsuda, S Hayashi, K Ishibashi… - World journal of surgical …, 2013 - Springer
Most tumorous lesions of the esophagus are esophageal cancers. Benign primary tumors of
the esophagus are uncommon, and account for approximately 2% of all esophageal tumors. …
the esophagus are uncommon, and account for approximately 2% of all esophageal tumors. …
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy
K Ishibashi, T Kumai, T Ohkuri, A Kosaka… - …, 2016 - Taylor & Francis
Tumor immune escape has been a major problem for developing effective immunotherapy.
The human leukocyte antigen G (HLA-G) is a non-classical MHC class I molecule whose …
The human leukocyte antigen G (HLA-G) is a non-classical MHC class I molecule whose …
